Global Injectable Drugs Market Insights, Forecast to 2025

Publisher Name :
Date: 17-May-2019
No. of pages: 113
Inquire Before Buying

Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body.

Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or diacetylmorphine/heroin; roughly two-thirds of which is destroyed in the liver when consumed orally) than oral ingestion would, meaning users get a stronger (yet shorter-acting) effect from the same amount of the drug.

The global Injectable Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Injectable Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Injectable Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Injectable Drugs in these regions.

This research report categorizes the global Injectable Drugs market by top players/brands, region, type and end user. This report also studies the global Injectable Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- AbbVie

- F. Hoffmann-La Roche

- GlaxoSmithKline

- Sanofi

Market size by Product

- Biologics

- Small molecules

Market size by End User

- Auto-immune diseases

- Hormonal Disorders

- Orphan Diseases

- Oncology

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Injectable Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Injectable Drugs market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Injectable Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Injectable Drugs submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Injectable Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Injectable Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Injectable Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Injectable Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Injectable Drugs Market Size Growth Rate by Product
1.4.2 Biologics
1.4.3 Small molecules
1.5 Market by End User
1.5.1 Global Injectable Drugs Market Size Growth Rate by End User
1.5.2 Auto-immune diseases
1.5.3 Hormonal Disorders
1.5.4 Orphan Diseases
1.5.5 Oncology
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Injectable Drugs Market Size
2.1.1 Global Injectable Drugs Revenue 2014-2025
2.1.2 Global Injectable Drugs Sales 2014-2025
2.2 Injectable Drugs Growth Rate by Regions
2.2.1 Global Injectable Drugs Sales by Regions
2.2.2 Global Injectable Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Injectable Drugs Sales by Manufacturers
3.1.1 Injectable Drugs Sales by Manufacturers
3.1.2 Injectable Drugs Sales Market Share by Manufacturers
3.1.3 Global Injectable Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Injectable Drugs Revenue by Manufacturers
3.2.1 Injectable Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Injectable Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Injectable Drugs Price by Manufacturers
3.4 Injectable Drugs Manufacturing Base Distribution, Product Types
3.4.1 Injectable Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Injectable Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Injectable Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Injectable Drugs Sales by Product
4.2 Global Injectable Drugs Revenue by Product
4.3 Injectable Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Injectable Drugs Breakdown Data by End User
6 North America
6.1 North America Injectable Drugs by Countries
6.1.1 North America Injectable Drugs Sales by Countries
6.1.2 North America Injectable Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Injectable Drugs by Product
6.3 North America Injectable Drugs by End User
7 Europe
7.1 Europe Injectable Drugs by Countries
7.1.1 Europe Injectable Drugs Sales by Countries
7.1.2 Europe Injectable Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Injectable Drugs by Product
7.3 Europe Injectable Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Injectable Drugs by Countries
8.1.1 Asia Pacific Injectable Drugs Sales by Countries
8.1.2 Asia Pacific Injectable Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Injectable Drugs by Product
8.3 Asia Pacific Injectable Drugs by End User
9 Central & South America
9.1 Central & South America Injectable Drugs by Countries
9.1.1 Central & South America Injectable Drugs Sales by Countries
9.1.2 Central & South America Injectable Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Injectable Drugs by Product
9.3 Central & South America Injectable Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Injectable Drugs by Countries
10.1.1 Middle East and Africa Injectable Drugs Sales by Countries
10.1.2 Middle East and Africa Injectable Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Injectable Drugs by Product
10.3 Middle East and Africa Injectable Drugs by End User
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 Company Business Overview
11.1.3 AbbVie Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AbbVie Injectable Drugs Products Offered
11.1.5 AbbVie Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 Company Business Overview
11.2.3 F. Hoffmann-La Roche Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 F. Hoffmann-La Roche Injectable Drugs Products Offered
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 Company Business Overview
11.3.3 GlaxoSmithKline Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 GlaxoSmithKline Injectable Drugs Products Offered
11.3.5 GlaxoSmithKline Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Injectable Drugs Products Offered
11.4.5 Sanofi Recent Development
12 Future Forecast
12.1 Injectable Drugs Market Forecast by Regions
12.1.1 Global Injectable Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Injectable Drugs Revenue Forecast by Regions 2019-2025
12.2 Injectable Drugs Market Forecast by Product
12.2.1 Global Injectable Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Injectable Drugs Revenue Forecast by Product 2019-2025
12.3 Injectable Drugs Market Forecast by End User
12.4 North America Injectable Drugs Forecast
12.5 Europe Injectable Drugs Forecast
12.6 Asia Pacific Injectable Drugs Forecast
12.7 Central & South America Injectable Drugs Forecast
12.8 Middle East and Africa Injectable Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Injectable Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Injectable Drugs Product Picture
Table Injectable Drugs Market Segments
Table Key Manufacturers Injectable Drugs Covered
Table Global Injectable Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Injectable Drugs Sales Market Share by Product 2014-2025
Figure Biologics Product Picture
Table Major Manufacturers of Biologics
Figure Small molecules Product Picture
Table Major Manufacturers of Small molecules
Table Global Injectable Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Auto-immune diseases
Figure Hormonal Disorders
Figure Orphan Diseases
Figure Oncology
Figure Injectable Drugs Report Years Considered
Figure Global Injectable Drugs Market Size 2014-2025 (Million US$)
Figure Global Injectable Drugs Sales 2014-2025 (K Units)
Table Global Injectable Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Injectable Drugs Sales by Regions 2014-2019 (K Units)
Table Global Injectable Drugs Sales Market Share by Regions 2014-2019
Figure Global Injectable Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Injectable Drugs Sales Market Share by Regions
Table Global Injectable Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Injectable Drugs Revenue Market Share by Regions 2014-2019
Figure Global Injectable Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Injectable Drugs Revenue Market Share by Regions
Table Global Injectable Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Injectable Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Injectable Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Injectable Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Injectable Drugs Revenue Share by Manufacturers (2014-2019)
Figure Injectable Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Injectable Drugs Price (2014-2019) (USD/Unit)
Table Injectable Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Injectable Drugs Product Type
Table Date of International Manufacturers Enter into Injectable Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Injectable Drugs Sales by Product (2014-2019) (K Units)
Table Global Injectable Drugs Sales Share by Product (2014-2019)
Figure Global Injectable Drugs Sales Market Share by Product (2014-2019)
Figure Global Injectable Drugs Sales Market Share by Product in 2018
Table Global Injectable Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Injectable Drugs Revenue Share by Product (2014-2019)
Figure Global Injectable Drugs Revenue Market Share by Product (2014-2019)
Figure Global Injectable Drugs Revenue Market Share by Product in 2018
Table Injectable Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Injectable Drugs Sales by End User (2014-2019) (K Units)
Table Global Injectable Drugs Sales Share by End User (2014-2019)
Figure Global Sales Injectable Drugs Market Share by End User (2014-2019)
Figure Global Sales Injectable Drugs Market Share by End User in 2018
Figure North America Injectable Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Injectable Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Injectable Drugs Sales by Countries (2014-2019) (K Units)
Table North America Injectable Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Injectable Drugs Sales Market Share by Countries
Table North America Injectable Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Injectable Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Injectable Drugs Revenue Market Share by Countries
Figure United States Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Injectable Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Injectable Drugs Sales by Product (2014-2019) (K Units)
Table North America Injectable Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Injectable Drugs Market Share by Product
Table North America Injectable Drugs Sales by End User (2014-2019) (K Units)
Table North America Injectable Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Injectable Drugs Market Share by End User
Figure Europe Injectable Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Injectable Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Injectable Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Injectable Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Injectable Drugs Sales Market Share by Countries
Table Europe Injectable Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Injectable Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Injectable Drugs Revenue Market Share by Countries
Figure Germany Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Injectable Drugs Sales by Product (2014-2019) (K Units)
Table Europe Injectable Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Injectable Drugs Market Share by Product
Table Europe Injectable Drugs Sales by End User (2014-2019) (K Units)
Table Europe Injectable Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Injectable Drugs Market Share by End User
Figure Asia Pacific Injectable Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Injectable Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Injectable Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Injectable Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Injectable Drugs Sales Market Share by Countries
Table Asia Pacific Injectable Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Injectable Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Injectable Drugs Revenue Market Share by Countries
Figure China Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Injectable Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Injectable Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Injectable Drugs Market Share by Product
Table Asia Pacific Injectable Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Injectable Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Injectable Drugs Market Share by End User
Figure Central & South America Injectable Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Injectable Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Injectable Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Injectable Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Injectable Drugs Sales Market Share by Countries
Table Central & South America Injectable Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Injectable Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Injectable Drugs Revenue Market Share by Countries
Figure Brazil Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Injectable Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Injectable Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Injectable Drugs Market Share by Product
Table Central & South America Injectable Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Injectable Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Injectable Drugs Market Share by End User
Figure Middle East and Africa Injectable Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Injectable Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Injectable Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Injectable Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Injectable Drugs Sales Market Share by Countries
Table Middle East and Africa Injectable Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Injectable Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Injectable Drugs Revenue Market Share by Countries
Figure GCC Countries Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Injectable Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Injectable Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Injectable Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Injectable Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Injectable Drugs Market Share by Product
Table Middle East and Africa Injectable Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Injectable Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Injectable Drugs Market Share by End User
Table AbbVie Company Details
Table AbbVie Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Sanofi Company Details
Table Sanofi Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Global Injectable Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Injectable Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Injectable Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Injectable Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Injectable Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Injectable Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Injectable Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Injectable Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Injectable Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Injectable Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Injectable Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Injectable Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Injectable Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Injectable Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Injectable Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Injectable Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Injectable Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Injectable Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Injectable Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Injectable Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Injectable Drugs Value Chain
Table Injectable Drugs Customers List
Table Injectable Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs